DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Braun J et al.
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study.
Ann Rheum Dis 2012;
71: 661-667
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.